Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.
Iran's Gulf neighbors have said attacks on energy infrastructure won't "go unanswered," but, so far, they have not hit back at Iran. That stance could change soon.